Journals / MN Oftalmoloji / 2017 / Cilt: 24 - Sayı: 3

Assessment of the Oxidant-Antioxidant Balance in Patients with Different Stages of Diabetic Retinopathy

Farklı Safhalardaki Diyabetik Retinopatili Hastalarda Oksidan-Antioksidan Dengesinin Değerlendirilmesi

Pages
154–159
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, no significant association was determined between stage of diabetic retinopathy and the oxidant-antioxidant balance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the oxidant-antioxidant balance in patients with findings from different stages of diabetic retinopathy.
📊
Key Findings & Data:Material and Method: 98 patients with type 2 diabetes mellitus, 30 with no diabetic retinopathy, 33 with non-proliferative diabetic retinopa thy and 35 with proliferative diabetic retinopathy, and 52 healthy controls were included in the study.
💡
Conclusion & Impact:However, no significant association was determined between stage of diabetic retinopathy and the oxidant-antioxidant balance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To investigate the oxidant-antioxidant balance in patients with findings from different stages of diabetic retinopathy. Material and Method: 98 patients with type 2 diabetes mellitus, 30 with no diabetic retinopathy, 33 with non-proliferative diabetic retinopa thy and 35 with proliferative diabetic retinopathy, and 52 healthy controls were included in the study. Total antioxidant capacity, total oxidant status and malondialdehyde levels were measured in serum specimens taken from all participants. Oxidative stress index values reflecting the total oxidant status /total antioxidant capacity ratio and malondialdehyde levels between the groups were subjected to statistical analysis. Results: Groups' mean serum total antioxidant capacity levels were 2.16±2.27 (0.19-12.28), 2.04±2.34 (0.25-12.84), 1.66±0.53 (0.49-2.98) and 1.95±0.58 (0.88-3.55) mmol Trolox equiv. / L, respectively. Mean total oxidant status levels were 2.38±2.66 (0.52-13.04), 1.2±1.33 (0.24- 7.5), 1.28±0.79 (0.27-3.85) and 0.66±0.19 (0.36-1.29) mmol H2O2 / L, respectively. Mean serum oxidative stress index levels were 0.2±0.32% (0.01-1.7), 0.16±0.51% (0.01-2.97), 0.09±0.06% (0.01-0.3) and 0.04±0.02% (0.02-0.07). Groups' mean serum malondialdehyde levels were 0.43±0.5 (0.13-2.42), 0.26±0.29 (0.11-1.78), 0.22±0.06 (0.13-0.36) and 0.17±0.11 (0.04-0.71) nmol / mL, respectively. Conclusion: Higher oxidative stress index and malondialdehyde levels being determined in the diabetic groups shows that the oxidativeantioxidative balance alters in favor of oxidative trauma in the presence of diabetes. However, no significant association was determined between stage of diabetic retinopathy and the oxidant-antioxidant balance.

Özet

Amaç: Farklı safhalarda diyabetik retinopati bulgularına sahip olan hastalarda oksidan-antioksidan dengesini araştırmak.Gereç veYöntem: Çalışmaya 30'u diyabetik retinopatisiz, 33'ü nonproliferatif diyabetik retinopatili ve 35'i proliferatif diyabetik retinopatili olmak üzere toplam 98 tip 2 diabetes mellituslu hasta ve 52 sağlıklı kontrol dahil edildi. Tüm katılımcılara ait serum örneklerinde toplamantioksidan kapasite, toplam oksidan kapasite ve malondialdehit seviyeleri ölçüldü. Toplam oksidan kapasite /toplam antioksidan kapasite oranını yansıtan oksidatif stres indeksi değerleri ve malondialdehit seviyeleri gruplar arasında istatistiksel olarak karşılaştırıldı. Bulgular: Sırasıyla gruplarda elde edilen ortalama serum toplam antioksidan kapasite seviyeleri 2,16±2,27 (0,19-12,28), 2,04±2,34 (0,2512,84), 1,66±0,53 (0,49-2,98), 1,95±0,58 (0,88-3,55) mmol Trolox equiv. / L idi. Sırasıyla gruplarda elde edilen ortalama serum toplam oksidan kapasite seviyeleri 2,38±2,66 (0,52-13,04), 1,2±1,33 (0,24-7,5), 1,28±0,79 (0,27-3,85), 0,66±0,19 (0,36-1,29) mmol H2O2/ L idi. Sırasıylagruplarda elde edilen ortalama serum oksidatif stres indeksi seviyeleri %0,2±0,32 (0,01-1.7), %0,16±0,51 (0,01-2,97), %0,09±0,06 (0,01-0,3),%0,04±0,02 (0,02-0,07) idi. Sırasıyla gruplarda elde edilen ortalama serum malondialdehit seviyeleri ise 0,43±0,5 (0,13-2,42), 0,26±0,29(0,11-1,78), 0.22±0,06 (0,13-0,36), 0,17±0,11 (0,04-0,71) nmol/mL idi.Sonuç: Çalışmada oksidatif stres indeksi ve malondialdehit seviyelerinin diyabetli gruplarda daha yüksek bulunması oksidan-antioksidandengesinin diyabet varlığında oksidatif travmaya doğru kaydığını göstermiştir. Ancak diyabetik retinopati safhası ile oksidan-antioksidan dengesinin bozulma derecesi arasında anlamlı bir ilişki bulunamamıştır.

🔖

Cite This Article

TÜRK, A., NUHOĞLU, İ., MENTEŞE, A., KOLA, M., DURAN, H., KARAHAN, S. C., ERDÖL, H., EREM, C. (2017). Assessment of the Oxidant-Antioxidant Balance in Patients with Different Stages of Diabetic Retinopathy. MN Oftalmoloji, Cilt: 24 - Sayı: 3, 154–159. https://ajindex.com/articles/295497

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Lim A, Stewart J, Chui TY, et al. Prevalence and risk factors of diabetic retinopathy in a multi-racial underserved population. Opht - hal mic Epidemiol 2008;15:402-9
  2. Mohamed Q, Gillies MC, Wong TY. Management of diabetic reti - nopathy: a systematic review. JAMA 2007;298:902-16
  3. Apaydın KC, Bilgin AB. Diyabetik retinopatide erken tanı ve medikal tedavi. Ret-Vit 2010;18:61-5
  4. Erdol H, Turk A, Akyol N, Imamoglu HI. The results of intravitreal bevacizumab injections for persistent neovascularizations in proliferative diabetic retinopathy after photocoagulation therapy. Retina 2010;30:570-7
  5. Neely KA, Quillen DA, Schachat AP, Gardner TW, Blankenship GW. Diabetic retinopathy. Med Clin North Am 1998;82:847-76
  6. Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde. Retina 2011; 31:602-8
  7. Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 2008;9:315-27
  8. Arden GB, Sivaprasad S. Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev 2011;7:291-304
  9. İnan S. Diabetik retinopati ve etiyopatogenezi. Kocatepe Tıp Der - gi si 2014;15:207-17
  10. Wu Y, Tang L, Chen B. Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives. Oxid Med Cell Longev 2014;2014:752387
  11. Kowluru RA, Mishra M. Oxidative stress, mitochondrial damage and diabetic retinopathy. Biochim Biophys Acta 2015;1852: 2474-83
  12. Turk A, Aykut M, Akyol N, et al. Serum anti-carbonic anhydrase antibodies and oxidant-antioxidant balance in patients with acute anterior uveitis. Ocul Immunol Inflamm 2014;22:127-32
  13. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997;43: 1209-14
  14. Fatani SH, Babakr AT, NourEldin EM, Almarzouki AA. Lipid peroxidation is associated with poor control of type-2 diabetes mellitus. Diabetes Metab Syndr 2016. pii:S1871-4021(15)30061-8
  15. Kowluru RA, Kennedy A. Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert Opin Investig Drugs 2001; 10:1665-76
  16. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007;2007:43603
  17. Srivatsan R, Das S, Gadde R, et